G1 Therapeutics to Provide Second Quarter 2021 Financial Results and Business Update on August 4, 2021

NEXT STORY
Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
PREV STORY
Research Antibodies Market Research Report by Function, by Operation, by Product, by Source, by Technology, by Type, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pernix Therapeutics Announces Reorganization of Senior Management Team

John Sedor Appointed CEO on a Permanent Basis Company Names Pharmaceutical Industry Veteran, Dr. ...

author_avatar
NASDAQ Market News

Medivir focuses exclusively on oncology and reorganizes to significantly reduce the cost structure

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces a reorganization of the ...

author_avatar
NASDAQ Market News

Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Third quarter revenue increased to $18.4 million compared to $14.0 million in 3Q 2017 ...

author_avatar
NASDAQ Market News